Kc Investment Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Kc Investment Advisors, LLC
- $268 Million
- Q2 2025
A detailed history of Kc Investment Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Kc Investment Advisors, LLC holds 75,000 shares of ARWR stock, worth $1.22 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
75,000
Previous 150,000
50.0%
Holding current value
$1.22 Million
Previous $1.91 Million
37.99%
% of portfolio
0.44%
Previous 0.46%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
298Shares Held
97.2MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$256 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$215 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$181 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$114 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$85.3 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.73B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...